Gary Miloscia

Gary Miloscia serves as President and CEO of Covectra since October 2015, leading an organization focused on serialization and medication adherence solutions for the pharmaceutical industry as well as authentication technologies for brand protection and anti-counterfeiting. Additionally, Gary is a member of the Board of Directors for PharmoRx Therapeutics, Inc., contributing to the development of medications aimed at improving dopamine signaling for central nervous system diseases. Prior to these roles, Gary held various leadership positions at Fidelity Investments from 2008 to 2015, providing financial planning and analysis across multiple business units, and served as VP of Financial Strategy and Analysis at Health Dialog in 2007. Earlier in Gary’s career, finance roles included Finance Director positions at American Express Company, encompassing oversight of business travel finance and risk management finance. Gary earned an MBA in Finance from Indiana University - Kelley School of Business and a BS in Finance from Rutgers University.